Mapping the regions of the complement inhibitor CD59 responsible for its species selective activity

Biochemistry

Volumn 36, Issue 31, 1997, Pages 9423-9428

  Yu, Jinghua ^a   Dong, Shanghong ^a,d   Rushmere, Neil K ^c   Morgan, B Paul ^c   Abagyan, Ruben ^b   Tomlinson, Stephen ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN ANTIBODY COMPLEX; ARTICLE; CHIMERA; CYTOLYSIS; GENE EXPRESSION; GENE INSERTION; GENE MAPPING; HOST CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; SPECIES DIFFERENTIATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD59; COMPLEMENT INACTIVATOR PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; RATS; RECOMBINANT FUSION PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; SPECIES SPECIFICITY;

EID: 0030849973     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi970832i     Document Type: Article

References (32)

1. Rollins, S. A., Zhao, J. I., Ninomiya, H., and Sims, P. J. (1991) Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9. J. Immunol. 146, 2345-2351.
2. Ninomiya, H., and Sims, P. J. (1992) The human complement regulatory protein CD59 binds to the alpha chain of C8 and to the "b" domain of C9, J. Biol. Chem. 267, 13675-13680.
3. Rollins, S. A., and Sims, P. J. (1990) The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9, J. Immunol. 144, 3478-3483.
4. Meri, S., Morgan, B. P., Davies, A., Daniels, R. H., Olavesen, M. G., Waldemann, H., and Lachmann, P. J. (1990) Human protectin (CD59), an 18-20 kD complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers, Immunology 72, 1-9.
5. Diamond, L. E., McCurry, K. R., Martin, M. J., McClellan, S. B., Oldham, E. R., Platt, J. L., and Logan, J. S. (1996) Characterization of transgenic pigs expressing functionally active human CD59 on cardiac endothelium, Transplantation 61, 1241-1249.
6. McCurry, K. R., Kooyman, D. L., Alvarado, C. G., Cotterell, A. H., Martin, M. J., Logan, J. S., and Platt, J. L. (1995) Human complement regulatory proteins protect swine-to-primate cardiac xenographs from humoral injury, Nat. Med. (N.Y.) 1, 423-427.
7. Tomlinson, S., Wang, Y., Ueda, E., and Esser, A. F. (1995) The expression and characterization of chimeric human/equine complement protein C9: localization of homologous restriction site, J. Immunol. 155, 436-444.
8. Huesler, T., Lockert, D. H., Kaufman, K. M., Sodetz, J. M., and Sims, P. J. (1995) Chimeras of human complement C9 reveal the site of complement regulatory protein CD59, J. Biol. Chem. 270, 3483-3486.
9. Seya, T., Okada, M., Hazeki, K., and Nagasawa, S. (1990) Regulatory system of guinea-pig complement C3b: two factor I-cofactor proteins on guinea-pig peritoneal granulocytes, Biochem. Biophys. Res. Commun. 170, 514-512.
10. Kim, Y. U., Kinoshita, T., Molina, H., Hourcade, D., Seya, T., Wagner, L. M., and Holers, V. M. (1995) Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein, J. Exp. Med. 181, 151-159.
11. Ish, C., Ong, G. L., Desai, N., and Mattes, M. J. (1993) The specificity of alternative complement pathway-mediated lysis of erythrocytes: a survey of complement and target cells from 25 species, Scand. J. Immunol. 38, 113-122.
12. Kennedy, S. P., Rollins, S. A., Burton, W. V., Sims, P. J., Bothwell, A. L. M., Squinto, S. P., and Zavoico, G. B. (1994) Protection of porcine aortic endothelial cells from complement-mediated cell lysis and activation by recombinant human CD59, Transplantation 57, 1494-1501.
13. Bodian, D. L., Davies, S. J., Morgan, B. P., and Rushmere, N. K. (1997) Mutational analysis of the active site and antibody epitopes of the complement-inhibitory glycoprotein, CD59, J. Exp. Med. 185, 507-516.
14. Yu, J., Abagyan, R. A., Dong, S., Gilbert, A., Nussenzweig, V., and Tomlinson, S. (1997) The mapping of the active site of CD59, J. Exp. Med. 185, 745-753.
15. Rushmere, N. K., Harrison, R. A., van der Berg, C. W., and Morgan, B. P. (1994) Molecular cloning of the rat analogue of human CD59: structural comparison with human CD59 and identification of a putative active site, Biochem. J. 304, 595-601.
16. Harlow, E., and Lane, D. (1988) Antibodies. A laboratory manual, Cold Spring Harbor Laboratory Press, Plainview, NY.
17. Diaz, R., Mayorga, L., and Stahl, P. (1988) In vitro fusion of endosomes following receptor-mediated endocytosis, J. Biol. Chem. 263, 6093-6100.
18. Hughes, T. R., Piddlesden, S. J., Williams, J. D., Harrison, R. A., and Morgan, B. P. (1992) Isolation and characterization of a membrane protein from rat erythrocytes which inhibits lysis by the membrane attack complex of rat complement, Biochem. J. 284, 169-176.
19. Nardin, E. H., Nussenzweig, V., and Nussenzweig, R. S. (1982) Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax, J. Exp. Med. 156, 20-30.
20. Shariff, A., and Luna, E. J. (1992) Diacylglycerol-stimulated formation of actin nucleation sites at plasma membranes, Science 256, 245-247.
21. Fletcher, C. M., Harrison, R. A., Lachmann, P. J., and Neuhaus, D. (1994) Structure of a soluble, glycosylated form of the human complement regulatory protein CD59, Structure 2, 185-199.
22. Kieffer, B., Driscoll, P. C., Campbell, I. D., Willis, A. C., Anton van der Merwe, P., and Davis, S. J. (1994) Three-dimensional solution structure of the extracellular region of the complement regulatory protein CD59, a new cell-surface protein domain related to snake venom neurotoxins, Biochemistry 33, 4471-4482.
23. Petranka, J., Zhao, J., Norris, J., Tweedy, N. B., Ware, R. E., Sims, P. J., and Rosse, W. F. (1996) Structure-function relationships of the complement regulatory protein, CD59, Blood Cell. Mol. Dis. 22, 281-295.
24. Weisman, H. F., Bartow, T., Leppo, M. K., Marsh, H. C., Carson, G. R., Consino, M. F., Boyle, M. P., Roux, K. H., Weisfeldt, M. L., and Fearon, D. T. (1990) Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischenic myocardial inflammation and necrosis, Science 249, 146-151.
25. Moran, P., Beasly, H., Gorrel, A., Martin, E., Gribling, P., Fuchs, H., Gillet, N., Burton, L. E., and Caras, I. W. (1992) Human recombinant soluble decay accelerating factor inhibits complement activation in vitro and in vivo, J. Immunol. 149, 1736-1743.
26. Chavez-Cartaya, R. E., DeSola, G. P., Wright, L., Jamieson, N. V., and White, D. J. (1995) Regulation of the complement cascade by soluble complement receptor type 1. Protective effect in experimental liver ischemia and reperfusion, Transplantation 59, 1047-1052.
27. Christiansen, D., Milland, J., Thorley, B. R., McKenzie, I. F., and Loveland, B. E. (1996) A functional analysis of recombinant soluble CD46 in vivo and a comparison with recombinant soluble forms of CD55 and CD35 in vitro, Eur. J. Immunol. 26, 578-585.
28. Matis, L. A., and Rollins, S. A. (1995) Complement-specific antibodies: Designing novel anti-inflammatories, Nat. Med. (N.Y.) 1, 839-842.
29. Roush, W. (1995) New ways to avoid organ rejection buoys hopes, Science 270, 234-235.
30. Fodor, W. L., Williams, B. L., Matis, L. A., Madri, J. A., Rollins, S. A., Knight, J. W., Velander, W., and Squinto, S. P. (1994) Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ transplantation, Proc. Natl. Acad. Sci. U.S.A. 91, 11153-11157.
31. Byrne, G. W., McCurry, K. R., Kagan, D., Quinn, C., Martin, M. J., Platt, J. L., and Logan, J. S. (1995) Protection of xenogeneic cardiac endothelium from human complement by expression of CD59 or DAF in transgenic mice, Transplantation 60, 1149-1156.
32. Sacks, D. H., and Bach, F. H. (1990) Immunology of xenograph rejection, Hum. Immunol. 28, 245-251.